DOCGO INC (DCGO) Stock Fundamental Analysis
NASDAQ:DCGO - Nasdaq - US2560861096 - Common Stock - Currency: USD
DCGO gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 102 industry peers in the Health Care Providers & Services industry. DCGO has a great financial health rating, but its profitability evaluates not so good. DCGO has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
DCGO had positive earnings in the past year.
DCGO had a positive operating cash flow in the past year.
Of the past 5 years DCGO 4 years were profitable.
The reported operating cash flow has been mixed in the past 5 years: DCGO reported negative operating cash flow in multiple years.
1.2 Ratios
DCGO has a Return On Assets of -0.15%. This is comparable to the rest of the industry: DCGO outperforms 46.08% of its industry peers.
With a Return On Equity value of -0.21%, DCGO perfoms like the industry average, outperforming 51.96% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.15% | ||
| ROE | -0.21% | ||
| ROIC | N/A |
ROA(3y)4.86%
ROA(5y)1.57%
ROE(3y)7.06%
ROE(5y)1.16%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
DCGO's Profit Margin has declined in the last couple of years.
DCGO's Operating Margin has declined in the last couple of years.
The Gross Margin of DCGO (34.03%) is better than 62.75% of its industry peers.
In the last couple of years the Gross Margin of DCGO has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for DCGO so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 34.03% |
OM growth 3Y-8.41%
OM growth 5YN/A
PM growth 3Y-24.17%
PM growth 5YN/A
GM growth 3Y0.21%
GM growth 5YN/A
2. Health
2.1 Basic Checks
DCGO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for DCGO has been reduced compared to 1 year ago.
Compared to 1 year ago, DCGO has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.28 indicates that DCGO is not a great score, but indicates only limited risk for bankruptcy at the moment.
DCGO's Altman-Z score of 2.28 is in line compared to the rest of the industry. DCGO outperforms 54.90% of its industry peers.
DCGO has a debt to FCF ratio of 0.55. This is a very positive value and a sign of high solvency as it would only need 0.55 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 0.55, DCGO belongs to the best of the industry, outperforming 89.22% of the companies in the same industry.
DCGO has a Debt/Equity ratio of 0.13. This is a healthy value indicating a solid balance between debt and equity.
DCGO's Debt to Equity ratio of 0.13 is fine compared to the rest of the industry. DCGO outperforms 71.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.13 | ||
| Debt/FCF | 0.55 | ||
| Altman-Z | 2.28 |
ROIC/WACCN/A
WACC7.96%
2.3 Liquidity
DCGO has a Current Ratio of 2.44. This indicates that DCGO is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 2.44, DCGO belongs to the best of the industry, outperforming 81.37% of the companies in the same industry.
A Quick Ratio of 2.44 indicates that DCGO has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 2.44, DCGO belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.44 | ||
| Quick Ratio | 2.44 |
3. Growth
3.1 Past
The earnings per share for DCGO have decreased strongly by -65.00% in the last year.
The Earnings Per Share has been decreasing by -9.93% on average over the past years.
The Revenue for DCGO has decreased by -26.01% in the past year. This is quite bad
DCGO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 24.60% yearly.
EPS 1Y (TTM)-65%
EPS 3Y-9.93%
EPS 5YN/A
EPS Q2Q%-190%
Revenue 1Y (TTM)-26.01%
Revenue growth 3Y24.6%
Revenue growth 5YN/A
Sales Q2Q%-50.01%
3.2 Future
Based on estimates for the next years, DCGO will show a very negative growth in Earnings Per Share. The EPS will decrease by -35.00% on average per year.
The Revenue is expected to decrease by -15.82% on average over the next years. This is quite bad
EPS Next Y-124.19%
EPS Next 2Y-62.07%
EPS Next 3Y-35%
EPS Next 5YN/A
Revenue Next Year-49.7%
Revenue Next 2Y-27.64%
Revenue Next 3Y-15.82%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 18.29, DCGO is valued on the expensive side.
68.63% of the companies in the same industry are more expensive than DCGO, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 26.03. DCGO is valued slightly cheaper when compared to this.
A Price/Forward Earnings ratio of 34.22 indicates a quite expensive valuation of DCGO.
DCGO's Price/Forward Earnings ratio is in line with the industry average.
DCGO is valuated expensively when we compare the Price/Forward Earnings ratio to 21.94, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.29 | ||
| Fwd PE | 34.22 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, DCGO is valued cheaply inside the industry as 92.16% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, DCGO is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 1.5 | ||
| EV/EBITDA | 5.27 |
4.3 Compensation for Growth
DCGO's earnings are expected to decrease with -35.00% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-62.07%
EPS Next 3Y-35%
5. Dividend
5.1 Amount
No dividends for DCGO!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
1.28
-0.11 (-7.91%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners54.36%
Inst Owner Change3.86%
Ins Owners7.98%
Ins Owner Change12.15%
Market Cap126.85M
Analysts83.08
Price Target5.15 (302.34%)
Short Float %7.23%
Short Ratio5.96
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-165.5%
Min EPS beat(2)-311.74%
Max EPS beat(2)-19.26%
EPS beat(4)1
Avg EPS beat(4)-84.64%
Min EPS beat(4)-311.74%
Max EPS beat(4)0.93%
EPS beat(8)2
Avg EPS beat(8)-66.93%
EPS beat(12)4
Avg EPS beat(12)-46.24%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-9.08%
Min Revenue beat(2)-9.68%
Max Revenue beat(2)-8.47%
Revenue beat(4)0
Avg Revenue beat(4)-5.03%
Min Revenue beat(4)-9.68%
Max Revenue beat(4)-0.57%
Revenue beat(8)4
Avg Revenue beat(8)0.9%
Revenue beat(12)7
Avg Revenue beat(12)1.96%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-18.74%
EPS NQ rev (1m)-107.7%
EPS NQ rev (3m)-310.42%
EPS NY rev (1m)-1337.53%
EPS NY rev (3m)-157.56%
Revenue NQ rev (1m)-22.53%
Revenue NQ rev (3m)-26.88%
Revenue NY rev (1m)-23.94%
Revenue NY rev (3m)-24.88%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.29 | ||
| Fwd PE | 34.22 | ||
| P/S | 0.24 | ||
| P/FCF | 1.5 | ||
| P/OCF | 1.4 | ||
| P/B | 0.41 | ||
| P/tB | 0.55 | ||
| EV/EBITDA | 5.27 |
EPS(TTM)0.07
EY5.47%
EPS(NY)0.04
Fwd EY2.92%
FCF(TTM)0.85
FCFY66.49%
OCF(TTM)0.91
OCFY71.45%
SpS5.25
BVpS3.12
TBVpS2.35
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.15% | ||
| ROE | -0.21% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 34.03% | ||
| FCFM | 16.2% |
ROA(3y)4.86%
ROA(5y)1.57%
ROE(3y)7.06%
ROE(5y)1.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.11%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-8.41%
OM growth 5YN/A
PM growth 3Y-24.17%
PM growth 5YN/A
GM growth 3Y0.21%
GM growth 5YN/A
F-Score5
Asset Turnover1.21
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.13 | ||
| Debt/FCF | 0.55 | ||
| Debt/EBITDA | 2.9 | ||
| Cap/Depr | 40.69% | ||
| Cap/Sales | 1.21% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 634.7% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.44 | ||
| Quick Ratio | 2.44 | ||
| Altman-Z | 2.28 |
F-Score5
WACC7.96%
ROIC/WACCN/A
Cap/Depr(3y)50.15%
Cap/Depr(5y)71.98%
Cap/Sales(3y)1.27%
Cap/Sales(5y)2.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-65%
EPS 3Y-9.93%
EPS 5YN/A
EPS Q2Q%-190%
EPS Next Y-124.19%
EPS Next 2Y-62.07%
EPS Next 3Y-35%
EPS Next 5YN/A
Revenue 1Y (TTM)-26.01%
Revenue growth 3Y24.6%
Revenue growth 5YN/A
Sales Q2Q%-50.01%
Revenue Next Year-49.7%
Revenue Next 2Y-27.64%
Revenue Next 3Y-15.82%
Revenue Next 5YN/A
EBIT growth 1Y-102.46%
EBIT growth 3Y14.13%
EBIT growth 5YN/A
EBIT Next Year-58.26%
EBIT Next 3Y0.41%
EBIT Next 5YN/A
FCF growth 1Y516.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y824.48%
OCF growth 3YN/A
OCF growth 5YN/A